Application of Thrombopoietin in Intestinal Tissue Injury Caused by Radiation
A technology of thrombopoietin and tissue damage, applied in the field of medicine, can solve the problem of high cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] TPO improves the survival rate of radiation-damaged mice
[0024] The experimental animals were C57BL / 6 mice, aged 6-8 weeks, weighing 18-20g, and the radiation source was Co 60 , radiation dose 8Gy. All mice were divided into 5 groups according to different doses, 10 in each group, treated with different doses of TPO drugs within 2 hours after radiation and administered continuously for 14 days, the control group was given placebo, and the administration method was intraperitoneal subcutaneous injection. After radiation, the mice were administered according to the experimental plan, and the state changes and daily death of the mice were recorded at the same time. Survival results see figure 1 .
Embodiment 2
[0026] After lethal dose of radiation injury, the repair of intestinal tissue by TPO administration at different times
[0027] A. Model diagram of intestinal repair experiment after radiation injury (see figure 2 )
[0028] According to the survival rate experiment, it is determined that the optimal TPO dosage after radiation is 50 μg / kg, so the TPO administration group set in the next experiment is this dosage group, and the C57BL / 6 mice are selected, and the age of the week is generally at 6-8 weeks, body weight 18-20g, in order to increase the degree of intestinal damage, the radiation dose was increased to 10Gy, and the radiation source was Co 60 . The experimental mice were divided into two groups, the TPO treatment group and the blank control group, 10-15 in each group, and were given TPO drug treatment and placebo treatment within 2 hours after radiation, for 14 consecutive days, and the way of administration was abdominal Subcutaneous injection.
[0029] In the e...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


